Nubeqa bags FDA green light
The drug has been approved under the governing body’s Priority Review designation.
31st July 2019
Latest news
Eli Lilly announces Verzenio survival benefit
Breast cancer is the most common cancer in women worldwide, with more than two million new cases diagnosed in 2018.
31st July 2019
Neuraxpharm launches first products in UK
It has also announced the appointment of the company’s new general manager, Craig Bowen.
31st July 2019
Biodesix, Immodulon team up for pancreatic cancer treatment
The partnership will focus on the analysis of the circulating proteome of advanced pancreatic cancer patients treated with IMM-10.
31st July 2019
RCGP warns new PM that we ‘cannot risk no-deal disruption’
Johnson also took a moment in his speech to announced that he wants to revisit and potentially reverse the sugar tax.
30th July 2019
£3m funding for MS, Parkinson’s
The money will go to a new UK ‘digital brain bank’, Europe’s largest brain and tissue bank, based in London.
30th July 2019
52 cases of malaria reported in Scotland
The figure is an increase of 4% from the 2017 total.
30th July 2019
IONTAS, Teva announce new antibody optimisation agreement
Teva recently halted its Ajovy clinical development.
30th July 2019
EMA positive opinion granted for Keytruda combo
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorisation.
30th July 2019
NICE expands draft recommendation for Lokelma
The news comes shortly after AZ announced positive results from a late-stage trial of the drug.
30th July 2019
Finals day location confirmed for the 2019 Marketer of the year competition
IQVIA have been confirmed to host the finals days for the 2019 PharmaTimes Marketer of the Year and also the Sales Awards at their offices in Reading.
30th July 2019
AZ presents strong H1 financial results
The sales numbers were boosted by oncology drugs such as Tagrisso, Imfinzi and Lynparza.
29th July 2019
Janssen’s ponesimod holds up against Aubagio in late-stage trial
The drug is a selective sphingosine-1-phosphate receptor 1 (S1P1) modulator.
29th July 2019
First convergent science centre launched in UK
Scientists are “re-imagining ultrasound technology to develop a treatment that can liquefy cancer cells in the body using microscopic bubbles”.
29th July 2019
ViiV submits regulatory application to EMA for investigational HIV combo
The application is for cabotegravir and Edurant (rilpivirine) as the first monthly, injectable treatment for HIV.
29th July 2019
